...
机译:静脉磷霉素治疗重症患者对碳青霉烯类耐药的肺炎克雷伯菌引起的医院感染的前瞻性评价
Intensive Care Unit ‘Henry Dunant’ Hospital Athens Greece;
Department of Medicine Tufts University School of Medicine Boston MA USA;
Department of Medicine ‘Henry Dunant’ Hospital Athens;
Department of Microbiology ‘Henry Dunant’ Hospital Athens Greece;
Alfa Institute of Biomedical Sciences (AIBS) Athens Greece;
Carbapenem-resistant Klebsiella pneumoniae; colistin; fosfomycin; ICU-acquired infection; mortality; ventilator-associated pneumonia;
机译:静脉磷霉素用于治疗重症患者对碳青霉烯类耐药的肺炎克雷伯菌引起的医院感染:前瞻性评估。
机译:重症患者对碳青霉烯耐药的肺炎克雷伯菌肺部定植的临床意义:从定植到血液感染
机译:基于药代动力学/药效学(PK / PD)模拟,优化静脉磷霉素联合碳青霉烯类药物的剂量以治疗重症患者的铜绿假单胞菌感染
机译:重新评估患者患者的喂养策略
机译:产生大范围β-内酰胺酶的肺炎克雷伯氏菌菌株对实验性感染的抗菌治疗
机译:用蒙特卡罗模拟测定临床病患者静脉注射患者患者患者治疗CarbapeNem耐药肠杆菌感染的评价
机译:静脉磷霉素治疗重症患者对碳青霉烯类耐药的肺炎克雷伯菌引起的医院感染的前瞻性评价